UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Humanistic burden in schizophrenia: A literature review

Journal of psychiatric research, 2014-07, Vol.54, p.85-93

2014

Volltextzugriff (PDF)

Direct healthcare cost of schizophrenia – European overview

European psychiatry, 2018-02, Vol.48 (1), p.79-92

2018

Volltextzugriff (PDF)

A SYSTEMATIC LITERATURE REVIEW ON UTILITIES FOR CHILDREN WITH ACUTE GASTROENTERITIS

Value in health, 2016-05, Vol.19 (3), p.A317-A317

2016

Volltextzugriff (PDF)

Clinical implications and cost-effectiveness analysis of rivaroxaban in patients with coronary artery disease or peripheral arterial disease in the Netherlands

Journal of medical economics, 2021-01, Vol.24 (1), p.1231-1239

2021

Volltextzugriff (PDF)

Evolution of Presence of Predominant Negative Symptoms in Patients with Schizophrenia

Value in health, 2014-11, Vol.17 (7), p.A766-A766

2014

Volltextzugriff (PDF)

Minimum Clinically Important Difference in the Calgary Depression Scale for Schizophrenia

Value in health, 2014-11, Vol.17 (7), p.A766-A766

2014

Volltextzugriff (PDF)

Should Changes in Drug Price Over Time be Considered in Cost-Effectiveness Analyses?

Value in health, 2014-11, Vol.17 (7), p.A548-A548

2014

Volltextzugriff (PDF)

Minimum Clinically Important Difference in the Global Assessment Functioning in Patients with Schizophrenia

Value in health, 2014-11, Vol.17 (7), p.A765-A766

2014

Volltextzugriff (PDF)

Evolution of Depressive Status in Patients with Schizophrenia: An Analysis of Patient Trajectories

Value in health, 2014-11, Vol.17 (7), p.A766-A766

2014

Volltextzugriff (PDF)

Public Beliefs and Attitudes about Schizophrenia, Major Depression and Psychotropic Medication in Tunisia

Value in health, 2014-11, Vol.17 (7), p.A770-A771

2014

Volltextzugriff (PDF)

Burden Associated with Agitation in Schizophrenia

Value in health, 2014-11, Vol.17 (7), p.A766-A766

2014

Volltextzugriff (PDF)

Population Access to Rotavirus Vaccination in Industrialized Countries: Lessons Learnt from Current Experience

Value in health, 2014-11, Vol.17 (7), p.A808-A808

2014

Volltextzugriff (PDF)

Determinants of Pertussis outbreaks and Lessons Learnt

Value in health, 2015-05, Vol.18 (3), p.A233-A233

2015

Volltextzugriff (PDF)

Economic Burden of Pertussis outbreak is Highly Dependent on Setting

Value in health, 2015-05, Vol.18 (3), p.A245-A245

2015

Volltextzugriff (PDF)

Depressive symptoms in schizophrenia: Eurosc findings

Value in health, 2014-05, Vol.17 (3), p.A212-A212

2014

Volltextzugriff (PDF)

Symptomatic remission in schizophrenia

Value in health, 2014-05, Vol.17 (3), p.A212-A212

2014

Volltextzugriff (PDF)

Utility decrements associated with treatment-related adverse events in schizophrenia

Value in health, 2014-05, Vol.17 (3), p.A219-A219

2014

Volltextzugriff (PDF)

Utility decrements associated with side effects in schizophrenia

Journal of medical economics, 2014-12, Vol.17 (12), p.853-861

2014

Volltextzugriff (PDF)

Comparison of Economic Evaluation Guidelines Between Japan and Other Asian Countries

Value in health, 2014-11, Vol.17 (7), p.A798-A798

2014

Volltextzugriff (PDF)

Social Contacts Reduce Negative Symptoms, Especially Emotional Withdrawal in Patients with Schizophrenia

Value in health, 2014-11, Vol.17 (7), p.A455-A455

2014

Volltextzugriff (PDF)

Healthcare resource use in schizophrenia, EuroSC findings

Journal of market access & health policy, 2017, Vol.5 (1), p.1372027-9

2017

Volltextzugriff (PDF)

Assessing the economic impact of Rx-to-OTC switches: systematic review and guidelines for future development

Journal of medical economics, 2013-06, Vol.16 (6), p.835-844

2013

Volltextzugriff (PDF)

Evaluation of Different Approaches for Confounding in Nonrandomised Observational Data: A Case-Study of Antipsychotics Treatment

Community mental health journal, 2014-08, Vol.50 (6), p.711-720

2014

Volltextzugriff (PDF)

Validation of Disease States in Schizophrenia: Comparison of Cluster Analysis Between the United States and European Populations

Value in health, 2013-11, Vol.16 (7), p.A610-A610

2013

Volltextzugriff (PDF)

Modelling the Natural History of Schizophrenia: Comparison of Naïve Versus Advanced Statistical Methods

Value in health, 2013-11, Vol.16 (7), p.A593-A593

2013

Volltextzugriff (PDF)

1 – 25 von 656

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(422)
Mit Volltextzugriff
(451)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(553)
Französisch
(103)
Deutsch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Humanistic burden in schizophrenia: A literature review

Direct healthcare cost of schizophrenia – European overview

A SYSTEMATIC LITERATURE REVIEW ON UTILITIES FOR CHILDREN WITH ACUTE GASTROENTERITIS

Clinical implications and cost-effectiveness analysis of rivaroxaban in patients with coronary artery disease or peripheral arterial disease in the Netherlands

Evolution of Presence of Predominant Negative Symptoms in Patients with Schizophrenia

Minimum Clinically Important Difference in the Calgary Depression Scale for Schizophrenia

Should Changes in Drug Price Over Time be Considered in Cost-Effectiveness Analyses?

Minimum Clinically Important Difference in the Global Assessment Functioning in Patients with Schizophrenia

Evolution of Depressive Status in Patients with Schizophrenia: An Analysis of Patient Trajectories

Public Beliefs and Attitudes about Schizophrenia, Major Depression and Psychotropic Medication in Tunisia

Burden Associated with Agitation in Schizophrenia

Population Access to Rotavirus Vaccination in Industrialized Countries: Lessons Learnt from Current Experience

Determinants of Pertussis outbreaks and Lessons Learnt

Economic Burden of Pertussis outbreak is Highly Dependent on Setting

Depressive symptoms in schizophrenia: Eurosc findings

Symptomatic remission in schizophrenia

Utility decrements associated with treatment-related adverse events in schizophrenia

Utility decrements associated with side effects in schizophrenia

Comparison of Economic Evaluation Guidelines Between Japan and Other Asian Countries

Social Contacts Reduce Negative Symptoms, Especially Emotional Withdrawal in Patients with Schizophrenia

Healthcare resource use in schizophrenia, EuroSC findings

Assessing the economic impact of Rx-to-OTC switches: systematic review and guidelines for future development

Evaluation of Different Approaches for Confounding in Nonrandomised Observational Data: A Case-Study of Antipsychotics Treatment

Validation of Disease States in Schizophrenia: Comparison of Cluster Analysis Between the United States and European Populations

Modelling the Natural History of Schizophrenia: Comparison of Naïve Versus Advanced Statistical Methods

Suchergebnisse filtern